those misunderstanding mentioned above to decrease HPV prevalence and future cancer incidence. However, even though the author intends to prove the safety by citing the pre-market studies of those vaccines, she still cannot invalidate the possibility of severe post-marketing side effects. In my opinion, follow-up studies longer than 10 years should be addressed to prove the long-term safety.
those misunderstanding mentioned above to decrease HPV prevalence and future cancer incidence. However, even though the author intends to prove the safety by citing the pre-market studies of those vaccines, she still cannot invalidate the possibility of severe post-marketing side effects. In my opinion, follow-up studies longer than 10 years should be addressed to prove the long-term safety.